Search research articles
Contact Us
Filters
Showing results (21-30 of 30) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 30 results.
International Journal of Radiation Oncology, Biology, Physics
|
April 1, 1989
Initial results of a phase I trial of continuous infusion SR 2508 (etanidazole): a radiation therapy oncology group study
C N Coleman, L Noll, A E Howes, et al.
Gynecologic Oncology
|
May 1, 1984
The current status of drug development of hypoxic cell radiosensitizers and their potential role in gynecologic oncology
C N Coleman, S C Ballon, A E Howes, et al.
Radiology
|
December 1, 1974
Acute and chronic effects of x irradiation on blood flow in the mouse limb
N L Horn, M Thompson, A E Howes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1988
Advanced epithelial ovarian cancer: salvage whole abdominal irradiation for patients with recurrent or persistent disease after combination chemotherapy
M F Schray, A Martinez, A E Howes, et al.
Gynecologic Oncology
|
May 1, 1986
Advanced epithelial ovarian cancer: toxicity of whole abdominal irradiation after operation, combination chemotherapy, and reoperation
M F Schray, A Martinez, A E Howes, et al.
Annals of Internal Medicine
|
December 1, 1983
Reduced cardiotoxicity of doxorubicin delivered on a weekly schedule. Assessment by endomyocardial biopsy
F M Torti, M R Bristow, A E Howes, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 1, 1992
Final report of the phase I trial of continuous infusion etanidazole (SR 2508): a Radiation Therapy Oncology Group study
C N Coleman, L Noll, N Riese, et al.
Cancer Research
|
January 1, 1987
Relationship between the neurotoxicity of the hypoxic cell radiosensitizer SR 2508 and the pharmacokinetic profile
C N Coleman, J Halsey, R S Cox, et al.
Gynecologic Oncology
|
June 11, 1992
Intraperitoneal radioimmunotherapy of refractory ovarian carcinoma utilizing iodine-131-labeled monoclonal antibody OC125
M G Muto, N J Finkler, A I Kassis, et al.
Cancer Research
|
July 1, 1986
Cardiotoxicity of epirubicin and doxorubicin: assessment by endomyocardial biopsy
F M Torti, M M Bristow, B L Lum, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 30) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 30 results.
International Journal of Radiation Oncology, Biology, Physics
|
April 1, 1989
Initial results of a phase I trial of continuous infusion SR 2508 (etanidazole): a radiation therapy oncology group study
C N Coleman, L Noll, A E Howes, et al.
Gynecologic Oncology
|
May 1, 1984
The current status of drug development of hypoxic cell radiosensitizers and their potential role in gynecologic oncology
C N Coleman, S C Ballon, A E Howes, et al.
Radiology
|
December 1, 1974
Acute and chronic effects of x irradiation on blood flow in the mouse limb
N L Horn, M Thompson, A E Howes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1988
Advanced epithelial ovarian cancer: salvage whole abdominal irradiation for patients with recurrent or persistent disease after combination chemotherapy
M F Schray, A Martinez, A E Howes, et al.
Gynecologic Oncology
|
May 1, 1986
Advanced epithelial ovarian cancer: toxicity of whole abdominal irradiation after operation, combination chemotherapy, and reoperation
M F Schray, A Martinez, A E Howes, et al.
Annals of Internal Medicine
|
December 1, 1983
Reduced cardiotoxicity of doxorubicin delivered on a weekly schedule. Assessment by endomyocardial biopsy
F M Torti, M R Bristow, A E Howes, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 1, 1992
Final report of the phase I trial of continuous infusion etanidazole (SR 2508): a Radiation Therapy Oncology Group study
C N Coleman, L Noll, N Riese, et al.
Cancer Research
|
January 1, 1987
Relationship between the neurotoxicity of the hypoxic cell radiosensitizer SR 2508 and the pharmacokinetic profile
C N Coleman, J Halsey, R S Cox, et al.
Gynecologic Oncology
|
June 11, 1992
Intraperitoneal radioimmunotherapy of refractory ovarian carcinoma utilizing iodine-131-labeled monoclonal antibody OC125
M G Muto, N J Finkler, A I Kassis, et al.
Cancer Research
|
July 1, 1986
Cardiotoxicity of epirubicin and doxorubicin: assessment by endomyocardial biopsy
F M Torti, M M Bristow, B L Lum, et al.
Page
of 3